Annual Drug Patent Expirations for TRELEGY+ELLIPTA Trelegy Ellipta is a drug marketed by Glaxosmithkline and is included in one NDA. It is available from one supplier. There are nineteen patents…
The post New patent expiration for Glaxosmithkline drug …
New patent expiration for Glaxosmithkline drug TRELEGY ELLIPTA Read Post »
Annual Drug Patent Expirations for ELESTRIN Elestrin is a drug marketed by Mylan Speciality Lp and is included in one NDA. It is available from one supplier. There are two…
The post New patent expiration for Mylan Speciality drug ELESTRIN appeared firs…
New patent expiration for Mylan Speciality drug ELESTRIN Read Post »
Annual Drug Patent Expirations for ARNUITY+ELLIPTA Arnuity Ellipta is a drug marketed by Glaxosmithkline and is included in one NDA. It is available from one supplier. There are eight patents…
The post New patent expiration for Glaxosmithkline drug ARN…
New patent expiration for Glaxosmithkline drug ARNUITY ELLIPTA Read Post »
BREO ELLIPTA (fluticasone furoate; vilanterol trifenatate) Glaxo grp ltd Patent: 6,537,983 Expiration: Aug 3, 2021 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business…
The post Drug Patent Expirations for t…
Drug Patent Expirations for the Week of August 1, 2021 Read Post »
TRELEGY ELLIPTA (fluticasone furoate; umeclidinium bromide; vilanterol trifenatate) Glaxosmithkline Patent: 6,759,398 Expiration: Aug 3, 2021 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business…
The post Dr…
Drug Patent Expirations for the Week of August 1, 2021 Read Post »
Annual Drug Patent Expirations for SPY+AGENT+GREEN+KIT Spy Agent Green Kit is a drug marketed by Novadaq Tech and is included in one NDA. It is available from one supplier. There…
The post New patent expiration for Novadaq Tech drug SPY AGENT GREEN KIT…
New patent expiration for Novadaq Tech drug SPY AGENT GREEN KIT Read Post »
Annual Drug Patent Expirations for KYNAMRO Kynamro is a drug marketed by Kastle Theraps Llc and is included in one NDA. There are four patents protecting this drug. This drug…
The post New patent expiration for Kastle Theraps drug KYNAMRO appeared firs…
New patent expiration for Kastle Theraps drug KYNAMRO Read Post »
Annual Drug Patent Expirations for PHOSLO+GELCAPS Phoslo Gelcaps is a drug marketed by Fresenius Medcl and is included in one NDA. It is available from three suppliers. There are two…
The post New patent expiration for Fresenius Medcl drug PHOSLO GELCA…
New patent expiration for Fresenius Medcl drug PHOSLO GELCAPS Read Post »
Annual Drug Patent Expirations for ZYVOX Zyvox is a drug marketed by Pfizer and is included in three NDAs. It is available from four suppliers. There are two patents protecting…
The post New patent expiration for Pfizer drug ZYVOX appeared first on Dru…
Annual Drug Patent Expirations for ABILIFY Abilify is a drug marketed by Otsuka and Otsuka Pharm Co Ltd and is included in six NDAs. It is available from two suppliers.…
The post New patent expiration for Otsuka drug ABILIFY appeared first on DrugPaten…